DLBCL

Neurotoxicity from CAR T-cell therapy: how can it be managed and who is at risk?

L:

The Lymphoma Hub is pleased to present a series of two interviews with Bianca Santomasso, Memorial Sloan Kettering Cancer Center, on the topic of neurotoxicity in CAR T therapy. Bianca Santomasso talks the Lymphoma Hub through the causes, management, and patients at risk of neurotoxicity during the ASCO 2019 annual meeting in Chicago, US.